open access

Vol 2, No 1 (2009)
ORIGINAL PAPERS
Published online: 2009-02-12
Get Citation

Alloimmunization in patients with autoimmune haemolytic anaemia and red cell genotyping to improve selection of blood for transfusion

Bogumiła Michalewska, Barbara Żupańska, Monika Pelc-Kłopotowska, Agnieszka Orzińska, Justyna Bednarz, Katarzyna Guz, Agnieszka Ożóg, Hanna Łopieńska, Beata Wojciechowska, Magdalena Łakomy, Ewa Brojer
Journal of Transfusion Medicine 2009;2(1):14-19.

open access

Vol 2, No 1 (2009)
ORIGINAL PAPERS
Published online: 2009-02-12

Abstract

Background: The presence of warm autoantibodies in the sera of patients with autoimmune haemolytic anaemia are the cause of incompatibility in the compatibility test, which produces difficulties in the detection of clinically significant alloantibodies thus generating the risk of haemolytic transfusion reactions. For such patients the selection of red cells for transfusion requires special procedures to ensure safety.
Material and methods:Alloimmunization was analyzed in 163 AIHA patients (155 with warm type and 8 with mixed type of autoantibodies). In all patients, red cell phenotyping for Rh, K, was performed prior to transfusion and in 53 of them, red cells were phenotyped additionally in Kidd, Duffy, S, s, k with genotyping as well.
Results: Clinically significant alloantibodies were found in 31 patients (19%). In all, 42 antibodies of different specificities were identified (in 7 cases we detected antibodies with two or more specificities) within the following blood group systems: Rh, Kell, Kidd, Duffy, MNS and LW. In 14 of the alloimmunized patients, auto- or alloadsorption was required for alloantibody detection. In the group of 53 patients, phenotyping of Rh, K, Kidd and S antigens was successful in 37 patients (70%) with serological tests only, whereas the extended phenotype for Duffy, s, k antigens was successful only in 9 patients (17%). In each case, the genotype results were consistent with the phenotype. In the remaining patients, the results of extended phenotyping with serological method proved unreliable, due either to mixed-field reactions (after recent transfusion < 3 months) or autoagglutination. Genotyping was useful for predicting the phenotype in such cases.
Conclusions: In addition to phenotyping, genotyping of red cells is necessary for establishing the extended phenotype in AIHA patients. Such procedure is important for blood transfusion safety.

Abstract

Background: The presence of warm autoantibodies in the sera of patients with autoimmune haemolytic anaemia are the cause of incompatibility in the compatibility test, which produces difficulties in the detection of clinically significant alloantibodies thus generating the risk of haemolytic transfusion reactions. For such patients the selection of red cells for transfusion requires special procedures to ensure safety.
Material and methods:Alloimmunization was analyzed in 163 AIHA patients (155 with warm type and 8 with mixed type of autoantibodies). In all patients, red cell phenotyping for Rh, K, was performed prior to transfusion and in 53 of them, red cells were phenotyped additionally in Kidd, Duffy, S, s, k with genotyping as well.
Results: Clinically significant alloantibodies were found in 31 patients (19%). In all, 42 antibodies of different specificities were identified (in 7 cases we detected antibodies with two or more specificities) within the following blood group systems: Rh, Kell, Kidd, Duffy, MNS and LW. In 14 of the alloimmunized patients, auto- or alloadsorption was required for alloantibody detection. In the group of 53 patients, phenotyping of Rh, K, Kidd and S antigens was successful in 37 patients (70%) with serological tests only, whereas the extended phenotype for Duffy, s, k antigens was successful only in 9 patients (17%). In each case, the genotype results were consistent with the phenotype. In the remaining patients, the results of extended phenotyping with serological method proved unreliable, due either to mixed-field reactions (after recent transfusion < 3 months) or autoagglutination. Genotyping was useful for predicting the phenotype in such cases.
Conclusions: In addition to phenotyping, genotyping of red cells is necessary for establishing the extended phenotype in AIHA patients. Such procedure is important for blood transfusion safety.
Get Citation

Keywords

autoimmune haemolytic anaemia; alloimmunization; autoantibodies; blood transfusion; red cell phenotyping; red cell genotyping

About this article
Title

Alloimmunization in patients with autoimmune haemolytic anaemia and red cell genotyping to improve selection of blood for transfusion

Journal

Journal of Transfusion Medicine

Issue

Vol 2, No 1 (2009)

Pages

14-19

Published online

2009-02-12

Bibliographic record

Journal of Transfusion Medicine 2009;2(1):14-19.

Keywords

autoimmune haemolytic anaemia
alloimmunization
autoantibodies
blood transfusion
red cell phenotyping
red cell genotyping

Authors

Bogumiła Michalewska
Barbara Żupańska
Monika Pelc-Kłopotowska
Agnieszka Orzińska
Justyna Bednarz
Katarzyna Guz
Agnieszka Ożóg
Hanna Łopieńska
Beata Wojciechowska
Magdalena Łakomy
Ewa Brojer

References (15)
  1. Engelfriet CP, Reesink HW, et al. Garratty G. The detection of alloantibodies against red cell in patients with warm-type autoimmune haemolytic anaemia. International Forum. Vox Sang. 2000; 78: 200–207.
  2. Klein HG, Anstee DJ. Mollison’s Blood transfusion in clinical medicine. 11 ed. Blackwell Publishing 2005: 254–273.
  3. Łętowska M. Medyczne zasady pobierania krwi, oddzielania jej składników i wydawania, obowiązujące w jednostkach organizacyjnych publicznej służby krwi. Rozdział 7. Instytut Hematologii i Transfuzjologii, Warszawa 2008.
  4. Branch DR, Petz LD. Detecting alloantibodies in patients with autoantibodies. Transfusion. 1999; 39(1): 6–10.
  5. Cid J, Ortín X, Pinacho A, et al. Use of polyethylene glycol for performing autologous adsorptions. Transfusion. 2005; 45(5): 694–697.
  6. Issitt PD, Combs MR, Bumgarner DJ, et al. Studies of antibodies in the sera of patients who have made red cell autoantibodies. Transfusion. 1996; 36(6): 481–486.
  7. James P, Rowe GP, Tozzo GG. Elucidation of alloantibodies in autoimmune haemolytic anaemia. Vox Sang. 1988; 54(3): 167–171.
  8. Laine ML, Beattie KM. Frequency of alloantibodies accompanying autoantibodies. Transfusion. 1985; 25(6): 545–546.
  9. Maley M, Bruce DG, Babb RG, et al. The incidence of red cell alloantibodies underlying panreactive warm autoantibodies. Immunohematology. 2005; 21(3): 122–125.
  10. Morel PA, Bergren MO, Frank BAA. simple method for the detection of alloantibody in the presence of warm autoantibody. Transfusion. 1978; 18: 388.
  11. Shirey RS, Boyd JS, Parwani AV, et al. Prophylactic antigen-matched donor blood for patients with warm autoantibodies: an algorithm for transfusion management. Transfusion. 2002; 42(11): 1435–1441.
  12. Wallhermfechtel MA, Pohl BA, Chaplin H. Alloimmunization in patients with warm autoantibodies. A retrospective study employing three donor alloabsorptions to aid in antibody detection. Transfusion. 1984; 24(6): 482–485.
  13. Hashmi G, Shariff T, Seul M, et al. A flexible array format for large-scale, rapid blood group DNA typing. Transfusion. 2005; 45(5): 680–688.
  14. Reid ME, Rios M, Powell VI, et al. DNA from blood samples can be used to genotype patients who have recently received a transfusion. Transfusion. 2000; 40(1): 48–53.
  15. Anstee DJ. Goodbye to agglutination and all that? Transfusion. 2005; 45(5): 652–653.

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

Czasopismo Journal of Transfusion Medicine dostęne jest również w Ikamed - księgarnia medyczna

Wydawcą serwisu jest Via Medica sp. z o.o. sp. komandytowa, ul. Świętokrzyska 73, 80–180 Gdańsk

tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail: viamedica@viamedica.pl